January 2, 2025
(Reuters) – Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the agency’s […]
January 2, 2025
TOPLINE: Combined exposure to dioxins and dioxin-like polychlorinated biphenyls (DL-PCBs) is significantly associated with an increased risk for obesity in adults, with 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) showing the […]
December 31, 2024
Many experts, over many years, have questioned the value of using body mass index (BMI) to determine a patient’s health status. “A person’s health is influenced […]
December 30, 2024
The US Food and Drug Administration (FDA) declined to approve sotagliflozin (Zynquista) as an adjunct to insulin therapy for people with type 1 diabetes (T1D) and […]
December 30, 2024
TOPLINE: A program combining theoretical training with free disposal containers can effectively increase knowledge and improve sharps waste disposal practices among patients with diabetes. METHODOLOGY: A […]
December 27, 2024
Glucagon-like peptide 1 (GLP-1) medications have become a powerful weight loss tool in a country where 40% of the population is obese. Patients taking these medications […]
December 24, 2024
More than two thirds of American counties don’t have an endocrinologist, according to a new analysis by GoodRx, a company that provides discount coupons for medications. […]
December 24, 2024
TOPLINE: Simultaneous screening for liver fibrosis during retinal scanning shows promise as a novel pathway for detecting advanced liver disease in patients with type 2 diabetes […]
December 23, 2024
The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide (Victoza, Novo Nordisk) to […]